[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?].
Boissonnas
A
A
Unité pour le Sevrage des Toxicomanes, Hôpital Cochin, Paris.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use; D004630:Emergencies; D015658:HIV Infections / Q000150:complications; D006556:Heroin Dependence / Q000534:rehabilitation; D006760:Hospitalization; D006801:Humans; D008691:Methadone / Q000008:administration & dosage / Q000627:therapeutic use; D009020:Morphine / Q000008:administration & dosage / Q000627:therapeutic use; D010045:Outpatients; D010348:Patient Care Team; D019966:Substance-Related Disorders / Q000150:complications / Q000534:rehabilitation*
D002047:Buprenorphine; D009020:Morphine; D008691:Methadone
Comment traiter un malade du SIDA, toxicomane, qui ne souhaite pas et/ou ne peut pas se sevrer? Existe-t-il des pratiques de substitution à l'hôpital? Faut-il poursuivre la substitution à la sortie de l'hôpital? Dans la mise en oeuvre de la prévention des affections opportunistes, la substitution peut-elle être un adjuvant utile?